- This event has passed.
The Clinician Medtech Executive: What is the clinician’s role in a medtech startup?
April 5 @ 1:00 pm - 2:30 pm EDT
Join Starfish Medical on April 5, 2023 as they speak with two renowned clinicians – and startup founders – that turned innovative ideas into successful publicly-traded medtech companies.
PAVmed Inc. Co-founder & CEO Lishan Aklog and Angiotech Pharmaceuticals & Ikomed Technologies Co-founder Lindsay Machan will share their insights, stories and lessons learned from their experience commercializing the first drug eluting stent and building a public company around early cancer detection.
What you’ll learn in The Clinician Medtech Executive:
• Lessons learned as co-founder and clinician
• Leveraging clinical insights and expertise
• Avoiding pitfalls
• Finding the right role for maximum impact
Scott Phillips, Medical Device Playbook and StarFish Medical Founder, hosts and moderates live audience Q&A with presenters.
Lindsay Machan, MD
Co-Founder, Angiotech Pharmaceuticals & Ikomed Technologies
Lindsay Machan, MD is an interventional radiologist at the Vancouver Hospital and Associate Professor of Radiology at the University of British Columbia, with associate appointments in the departments of Vascular Surgery and Urology. He mentors young innovators as a Fellow in the Creative Destruction Lab at the Sauder Business School at UBC and Haskayne Business School at the University of Calgary, and as a Founding Board Member of Endeavor Canada. In 2006 he shared the Manning Innovation Principle Award for the development of the paclitaxel eluting stent.
He has cofounded 3 medtech companies, sits on 4 corporate, 2 scientific advisory and 1 charitable board. His current academic research interests include mechanical methods of radiation reduction from fluoroscopy, ballistic embolic particles and novel excipients for local drug delivery.
Lishan Aklog, MD
Chairman & CEO, PAVmed Inc.
Dr. Lishan Aklog is Chairman & CEO of PAVmed (Nasdaq: PAVM), a diversified medical technology company which he co-founded, and its subsidiary Lucid Diagnostics, a cancer prevention company (Nasdaq: LUCD) as well as Executive Chairman of it other subsidiary Veris Health, a cancer care digital health company. He also serves on the board of the leading medtech industry group, AdvaMed, and as an independent public company director. He previously co-founded a medtech holding company which founded four medical device companies and led one of its portfolio companies, which commercialized one of his life-saving inventions, AngioVac®.
Dr. Aklog has consulted for leading medtech companies and is an inventor on dozens of patents. Healthcare Technology Report recognized him as a Top Healthcare Technology CEO of 2021 and 2022.